Soragni:Lab
@soragnilab
Of aggregation, rare cancer biology and organoids
First gen/Assist Prof @UCLA
Board @TheSFPM
Founder: Icona BioDx
bsky.app/profile/alice.…
ID: 802302308226736128
http://soragnilab.com 26-11-2016 00:05:51
11,11K Tweet
7,7K Takipçi
1,1K Takip Edilen
Together with Dr Jennifer Ashworth, we are delighted to share our recent review in Nature Reviews Cancer on "The importance of 3D matrix architecture in cancer & implications for biomaterial model design" → rdcu.be/dK15H ← Garvan Institute of Medical Research University of Nottingham Vet School Uni of Nottingham School of Medicine #WeAreUoN University of Nottingham Biodiscovery Institute
July is #SarcomaAwareness Month. This new commentary outlines the proposed strategic approach of the Children’s Oncology Group Soft Tissue Sarcoma Committee to the next generation of rhabdomyosarcoma clinical trials, focusing on five themes. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @oncoalert Abby Rosenberg, MD, MS, MA
Excited to have this one out - huge thanks to Cancer Research Southwest Airlines Chris Iacobuzio for the opportunity to describe the role of mathematicians in cancer research aacrjournals.org/cancerres/arti…
Our new paper is out! PDX engraftment predicts early recurrence/death in patients with early stage TNBC (better than pCR). Thanks to the great collaborative group Huntsman Cancer Institute - we’re working “towards” better precision care in breast cancer! ascopubs.org/doi/10.1200/PO…
Congrats! Proud to support Soragni:Lab! The lack of therapies for #cNF stems from the complexity of their cell composition. Dr. Soragni & team developed a high-throughput organoid screening platform that rapidly tests 3D tumor organoids for drug efficacy. Great work! #NF1
Dr. Alice Soragni (Soragni:Lab) and her team has developed a high throughput organoid screening platform to rapidly establish & screen 3D tumor organoids for cutaneous neurofibromas to find drugs that slow tumor growth. Read about the recent development: bit.ly/3WZxPDM